BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Dow
Accenture
Moodys
US Department of Justice
Baxter
Cerilliant
Farmers Insurance
Colorcon
Healthtrust

Generated: January 19, 2018

DrugPatentWatch Database Preview

Estrogens, conjugated; meprobamate - Generic Drug Details

« Back to Dashboard

What are the generic sources for estrogens, conjugated; meprobamate and what is the scope of estrogens, conjugated; meprobamate freedom to operate?

Estrogens, conjugated; meprobamate
is the generic ingredient in four branded drugs marketed by Medpointe Pharm Hlc and Wyeth Ayerst, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estrogens, conjugated; meprobamate.
Summary for estrogens, conjugated; meprobamate

US Patents and Regulatory Information for estrogens, conjugated; meprobamate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst PMB 400 estrogens, conjugated; meprobamate TABLET;ORAL 010971-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc MILPREM-400 estrogens, conjugated; meprobamate TABLET;ORAL 011045-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc MILPREM-200 estrogens, conjugated; meprobamate TABLET;ORAL 011045-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst PMB 200 estrogens, conjugated; meprobamate TABLET;ORAL 010971-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for estrogens, conjugated; meprobamate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst PMB 200 estrogens, conjugated; meprobamate TABLET;ORAL 010971-005 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Wyeth Ayerst PMB 400 estrogens, conjugated; meprobamate TABLET;ORAL 010971-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chubb
Express Scripts
Colorcon
Julphar
Teva
Novartis
Chinese Patent Office
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot